Sprain
Conditions
Keywords
sprains of the proximal interphalangeal joints of the long fingers, Diprophos
Brief summary
There is currently no real consensus on the optimal management of acute sprains of the proximal interphalangeal joint of the long fingers. The aim of this study is to assess the beneficial effect of an injection of corticosteroids for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute phase). This treatment, if effective, might become the treatment of choice for these types of injuries, instead of a prolonged immobilization or a careful early mobilization.
Interventions
DRUGDiprophos
Single subcutaneous injection of Diprophos, in the acute phase.
Sponsors
Brugmann University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Adults over 18 years old * Type I and II and III of the Eaton classification (except if fracture/luxation with more than 50% of the articular surface injured) * Trauma of one articulation only * Consultation within 2 weeks of trauma
Exclusion criteria
* Patients under 18 years old and over 80 years old * Pregnant/nursing women * Eaton classification Type II with a fracture affecting more than 50% of the articular surface, or persistant instability after reduction. * Open wounds, nerve lesion with sensitive issue and any wound needing a surgical intervention * Underlying pathologies: rhumatological, neurological, congenital (giving hyperextensive articulations as a result) * Corticoids allergy * Infection within the treated zone * Trauma antecedents at the level of the tendons.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Flexion/extension deficit | Baseline (day of kenacort injection) | Evaluation of the maximal amplitude of the articulation, as measured by a goniometer. |
| Laxity in hyperextension | Baseline (day of kenacort injection) | Evaluation of the maximal amplitude of the articulation, as measured by a goniometer. |
| Diameter of the articulation | Baseline (day of kenacort injection) | Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio |
| Prehension force | Baseline (day of kenacort injection) | Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mini-DASH | 7 days after injection | Assessment of the return to daily life activities or sport activities. Questionnaire of the Disabilities of the Arm, Shoulder and Hand. |
| Mitchigan Hand Questionnaire | 7 days after injection | Auto-evaluation of the patient regarding the functionality of his/her articulation |
| EVA scale | 7 days after injection | Pain assessment at the level of the volar plate |
Countries
Belgium
Outcome results
None listed